Edgewell Personal Care (EPC)
(Delayed Data from NYSE)
$39.19 USD
-0.07 (-0.18%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $39.13 -0.06 (-0.15%) 4:48 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$39.19 USD
-0.07 (-0.18%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $39.13 -0.06 (-0.15%) 4:48 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Zacks News
Edgewell Personal Care (EPC) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Edgewell Personal (EPC) delivered earnings and revenue surprises of 60% and 5.98%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
ARKO Corp. (ARKO) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
ARKO Corp. (ARKO) delivered earnings and revenue surprises of -200% and 0.55%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Edgewell Personal Care (EPC) Q2 Earnings Expected to Decline
by Zacks Equity Research
Edgewell Personal (EPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Buy Stocks for February 9th
by Zacks Equity Research
DB, SLF, TME, EPC and IFS have been added to the Zacks Rank #1 (Strong Buy) List on February 9, 2022.
Hain Celestial (HAIN) Q2 Earnings Beat Mark, Sales Dip Y/Y
by Zacks Equity Research
Hain Celestial (HAIN) reports soft sales results for second-quarter fiscal 2023. Several challenges and unfavorable foreign currency translations hurt results.
Edgewell Personal Care (EPC) Beats Q1 Earnings Estimates
by Zacks Equity Research
Edgewell Personal (EPC) delivered earnings and revenue surprises of 47.62% and 0.39%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Energizer (ENR) Q1 Earnings & Sales Miss Estimates, Down Y/Y
by Zacks Equity Research
Energizer (ENR) posts soft first-quarter fiscal 2023 results. Organic sales fall 5.4% in the quarter under review, driven by weak volumes and category declines.
Analysts Estimate Edgewell Personal Care (EPC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Edgewell Personal (EPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Investors Undervaluing Ahold (ADRNY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Albertsons Companies (ACI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Ahold (ADRNY) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
New Strong Sell Stocks for January 5th
by Zacks Equity Research
EPC, ITRI and BLWYY have been added to the Zacks Rank #5 (Strong Sell) List on January 5, 2023.
Edgewell Personal Care (EPC) Q4 Earnings Top Estimates
by Zacks Equity Research
Edgewell Personal (EPC) delivered earnings and revenue surprises of 2.60% and 0.74%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: ThredUp (TDUP) Q3 Earnings Expected to Decline
by Zacks Equity Research
ThredUp (TDUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Edgewell Personal Care (EPC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Edgewell Personal (EPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Edgewell Personal Care (EPC) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Edgewell Personal (EPC) delivered earnings and revenue surprises of 22.86% and 2.06%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Edgewell Personal Care (EPC) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Edgewell Personal (EPC) delivered earnings and revenue surprises of -9.09% and 1.46%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Edgewell Personal Care (EPC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Edgewell Personal (EPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for February 22nd
by Zacks Equity Research
DZSI, EPC, and LOPE have been added to the Zacks Rank #5 (Strong Sell) List on February 22, 2022
New Strong Sell Stocks for February 11th
by Zacks Equity Research
ALGN, CNHI, EPC, GHM, and HNGR have been added to the Zacks Rank #5 (Strong Sell) List on February 11, 2022.
Edgewell Personal Care (EPC) Q1 Earnings Match Estimates
by Zacks Equity Research
Edgewell Personal (EPC) delivered earnings and revenue surprises of 0% and 0.12%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Edgewell Personal Care (EPC) This Earnings Season?
by Zacks Equity Research
Edgewell Personal Care (EPC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for International Flavors' (IFF) Q4 Earnings?
by Zacks Equity Research
International Flavors' (IFF) Q4 results are likely to reflect benefits from robust demand for home care and personal categories, while high costs might have been a spoilsport.
Are Investors Undervaluing These Consumer Staples Stocks Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Edgewell Personal Care (EPC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Edgewell Personal (EPC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.